Human plasmacytoid dendritic cells induce CD8+LAG-3+Foxp3+CTLA-4+ regulatory T cells that suppress allo-reactive memory T cells

European Journal of Immunology

Volumn 41, Issue 6, 2011, Pages 1663-1674

  Boor, Patrick P C ^a   Metselaar, Herold J ^a   Jonge, Sarina de ^a   Mancham, Shanta ^a   van der Laan, Luc J W ^a   Kwekkeboom, Jaap ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CTLA 4; Immunotherapy; LAG 3; Transplantation; Tregs

Indexed keywords

CD45RO ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GRANZYME A; GRANZYME B; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 6; LYMPHOCYTE ACTIVATION GENE 3 PROTEIN; PROTEIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD8; CELLS, CULTURED; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; ISOANTIGENS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TRYPTOPHAN;

EID: 79957573911     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041229     Document Type: Article

References (64)

1. Roncarolo, M. G. and Battaglia, M., Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 2007. 7: 585-598.
2. Wood, K. J. and Sakaguchi, S., Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 2003. 3: 199-210.
3. Thomson, C. W., Lee, B. P. and Zhang, L., Double-negative regulatory T cells: non-conventional regulators. Immunol. Res. 2006. 35: 163-178.
4. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K. and Levings, M. K., Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 2006. 212: 28-50.
5. Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S. et al., Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 2002. 3: 237-243.
6. Jarvis, L. B., Matyszak, M. K., Duggleby, R. C., Goodall, J. C., Hall, F. C. and Gaston, J. S., Autoreactive human peripheral blood CD8+T cells with a regulatory phenotype and function. Eur. J. Immunol. 2005. 35: 2896-2908.
7. Uss, E., Rowshani, A. T., Hooibrink, B., Lardy, N. M., van Lier, R. A. and ten Berge, I. J., CD103 is a marker for alloantigen-induced regulatory CD8+T cells. J. Immunol. 2006. 177: 2775-2783.
8. Joosten, S. A., van Meijgaarden, K. E., Savage, N. D., de Boer, T., Triebel, F., van der Wal, A., de Heer, E. et al., Identification of a human CD8+regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 2007. 104: 8029-8034.
9. Lu, L. and Cantor, H., Generation and regulation of CD8(+) regulatory T cells. Cell. Mol. Immunol. 2008. 5: 401-406.
10. Guillonneau, C., Hill, M., Hubert, F. X., Chiffoleau, E., Herve, C., Li, X. L., Heslan, M. et al., CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2, 3-dioxygenase. J. Clin. Invest. 2007. 117: 1096-1106.
11. Li, X. L., Menoret, S., Bezie, S., Caron, L., Chabannes, D., Hill, M., Halary, F. et al., Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J. Immunol. 2010. 185: 823-833.
12. Sanchez-Fueyo, A., Sandner, S., Habicht, A., Mariat, C., Kenny, J., Degauque, N., Zheng, X. X. et al., Specificity of CD4+CD25+regulatory T cell function in alloimmunity. J. Immunol. 2006. 176: 329-334.
13. Karim, M., Feng, G., Wood, K. J. and Bushell, A. R., CD25+CD4+regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. Blood 2005. 105: 4871-4877.
14. Xia, G., He, J. and Leventhal, J. R., Ex vivo-expanded natural CD4+CD25+regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts. Am. J. Transplant. 2008. 8: 298-306.
15. Joffre, O., Santolaria, T., Calise, D., Al Saati, T., Hudrisier, D., Romagnoli, P. and van Meerwijk, J. P., Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+regulatory T lymphocytes. Nat. Med. 2008. 14: 88-92.
16. Tsang, J. Y., Tanriver, Y., Jiang, S., Xue, S. A., Ratnasothy, K., Chen, D., Stauss, H. J. et al., Conferring indirect allospecificity on CD4+CD25+Tregss by TCR gene transfer favors transplantation tolerance in mice. J. Clin. Invest. 2008. 118: 3619-3628.
17. Lombardi, G., Sidhu, S., Daly, M., Batchelor, J. R., Makgoba, W. and Lechler, R. I., Are primary alloresponses truly primary? Int. Immunol. 1990. 2: 9-13.
18. Macedo, C., Orkis, E. A., Popescu, I., Elinoff, B. D., Zeevi, A., Shapiro, R., Lakkis, F. G. and Metes, D., Contribution of naive and memory T-cell populations to the human alloimmune response. Am. J. Transplant. 2009. 9: 2057-2066.
19. London, C. A., Lodge, M. P. and Abbas, A. K., Functional responses and costimulator dependence of memory CD4+T cells. J. Immunol. 2000. 164: 265-272.
20. Taylor, D. K., Neujahr, D. and Turka, L. A., Heterologous immunity and homeostatic proliferation as barriers to tolerance. Curr. Opin. Immunol. 2004. 16: 558-564.
21. Valujskikh, A., The challenge of inhibiting alloreactive T-cell memory. Am. J. Transplant. 2006. 6: 647-651.
22. Dai, Z., Li, Q., Wang, Y., Gao, G., Diggs, L. S., Tellides, G. and Lakkis, F. G., CD4+CD25+regulatory T cells suppress allograft rejection mediated by memory CD8+T cells via a CD30-dependent mechanism. J. Clin. Invest. 2004. 113: 310-317.
23. Yang, J., Brook, M. O., Carvalho-Gaspar, M., Zhang, J., Ramon, H. E., Sayegh, M. H., Wood, K. J. et al., Allograft rejection mediated by memory T cells is resistant to regulation. Proc. Natl. Acad. Sci. USA 2007. 104: 19954-19959.
24. Welsh, R. M. and Selin, L. K., No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2002. 2: 417-426.
25. Adams, A. B., Williams, M. A., Jones, T. R., Shirasugi, N., Durham, M. M., Kaech, S. M., Wherry, E. J. et al., Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 2003. 111: 1887-1895.
26. Lechler, R. I., Sykes, M., Thomson, A. W. and Turka, L. A., Organ transplantation--how much of the promise has been realized? Nat. Med. 2005. 11: 605-613.
27. Pearl, J. P., Parris, J., Hale, D. A., Hoffmann, S. C., Bernstein, W. B., McCoy, K. L., Swanson, S. J. et al., Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am. J. Transplant. 2005. 5: 465-474.
28. Lechler, R. I., Garden, O. A. and Turka, L. A., The complementary roles of deletion and regulation in transplantation tolerance. Nat. Rev. Immunol. 2003. 3: 147-158.
29. Ochando, J. C., Homma, C., Yang, Y., Hidalgo, A., Garin, A., Tacke, F., Angeli, V. et al., Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 2006. 7: 652-662.
30. Abe, M., Wang, Z., de Creus, A. and Thomson, A. W., Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 2005. 5: 1808-1819.
31. Fugier-Vivier, I. J., Rezzoug, F., Huang, Y., Graul-Layman, A. J., Schanie, C. L., Xu, H., Chilton, P. M. and Ildstad, S. T., Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 2005. 201: 373-383.
32. Hadeiba, H., Sato, T., Habtezion, A., Oderup, C., Pan, J. and Butcher, E. C., CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 2008. 9: 1253-1260.
33. Goubier, A., Dubois, B., Gheit, H., Joubert, G., Villard-Truc, F., Asselin-Paturel, C., Trinchieri, G. and Kaiserlian, D., Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008. 29: 464-475.
34. Dubois, B., Joubert, G., Gomez de Aguero, M., Gouanvic, M., Goubier, A. and Kaiserlian, D., Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Gastroenterology 2009. 137: 1019-1028.
35. Irla, M., Kupfer, N., Suter, T., Lissilaa, R., Benkhoucha, M., Skupsky, J., Lalive, P. H. et al., MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J. Exp. Med. 2010. 207: 1891-1905.
36. Ouabed, A., Hubert, F. X., Chabannes, D., Gautreau, L., Heslan, M. and Josien, R., Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells. J. Immunol. 2008. 180: 5862-5870.
37. Gilliet, M. and Liu, Y. J., Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 2002. 195: 695-704.
38. Moseman, E. A., Liang, X., Dawson, A. J., Panoskaltsis-Mortari, A., Krieg, A. M., Liu, Y. J., Blazar, B. R. and Chen, W., Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+regulatory T cells. J. Immunol. 2004. 173: 4433-4442.
39. Kawamura, K., Kadowaki, N., Kitawaki, T. and Uchiyama, T., Virus-stimulated plasmacytoid dendritic cells induce CD4+cytotoxic regulatory T cells. Blood 2006. 107: 1031-1038.
40. Ito, T., Yang, M., Wang, Y. H., Lande, R., Gregorio, J., Perng, O. A., Qin, X. F. et al., Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007. 204: 105-115.
41. Chen, W., Liang, X., Peterson, A. J., Munn, D. H. and Blazar, B. R., The indoleamine 2, 3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 2008. 181: 5396-5404.
42. Manches, O., Munn, D., Fallahi, A., Lifson, J., Chaperot, L., Plumas, J. and Bhardwaj, N., HIV-activated human plasmacytoid DCs induce Tregss through an indoleamine 2, 3-dioxygenase-dependent mechanism. J. Clin. Invest. 2008. 118: 3431-3439.
43. Sallusto, F., Lanzavecchia, A. and Mackay, C. R., Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 1998. 19: 568-574.
44. Cosmi, L., Liotta, F., Lazzeri, E., Francalanci, M., Angeli, R., Mazzinghi, B., Santarlasci, V. et al., Human CD8+CD25+thymocytes share phenotypic and functional features with CD4+CD25+regulatory thymocytes. Blood 2003. 102: 4107-4114.
45. Joosten, S. A. and Ottenhoff, T. H., Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum. Immunol. 2008. 69: 760-770.
46. Koch, S. D., Uss, E., van Lier, R. A. and ten Berge, I. J., Alloantigen-induced regulatory CD8+CD103+T cells. Hum. Immunol. 2008. 69: 737-744.
47. Correale, J. and Villa, A., Isolation and characterization of CD8+regulatory T cells in multiple sclerosis. J. Neuroimmunol. 2008. 195: 121-134.
48. Lieberman, J., Granzyme A activates another way to die. Immunol. Rev. 2010. 235: 93-104.
49. Afonina, I. S., Cullen, S. P. and Martin, S. J., Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol. Rev. 2010. 235: 105-116.
50. Motyka, B., Korbutt, G., Pinkoski, M. J., Heibein, J. A., Caputo, A., Hobman, M., Barry, M. et al., Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 2000. 103: 491-500.
51. Gross, C., Koelch, W., DeMaio, A., Arispe, N. and Multhoff, G., Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B. J. Biol. Chem. 2003. 278: 41173-41181.
52. Vlad, G., Cortesini, R. and Suciu-Foca, N., CD8+T suppressor cells and the ILT3 master switch. Hum. Immunol. 2008. 69: 681-686.
53. Huang, C. T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L. et al., Role of LAG-3 in regulatory T cells. Immunity 2004. 21: 503-513.
54. Liang, B., Workman, C., Lee, J., Chew, C., Dale, B. M., Colonna, L., Flores, M. et al., Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J. Immunol. 2008. 180: 5916-5926.
55. Bayry, J., Triebel, F., Kaveri, S. V. and Tough, D. F., Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+regulatory T cells. J. Immunol. 2007. 178: 4184-4193.
56. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T. and Sakaguchi, S., CTLA-4 control over Foxp3+regulatory T cell function. Science 2008. 322: 271-275.
57. Zheng, Y., Manzotti, C. N., Burke, F., Dussably, L., Qureshi, O., Walker, L. S. and Sansom, D. M., Acquisition of suppressive function by activated human CD4+CD25- T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol. 2008. 181: 1683-1691.
58. Sansom, D. M. and Walker, L. S., The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol. Rev. 2006. 212: 131-148.
59. Koyama, M., Hashimoto, D., Aoyama, K., Matsuoka, K., Karube, K., Niiro, H., Harada, M. et al., Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells. Blood 2009. 113: 2088-2095.
60. Boor, P. P., Metselaar, H. J., Mancham, S., Tilanus, H. W., Kusters, J. G. and Kwekkeboom, J., Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells. Am. J. Transplant. 2006. 6: 2332-2341.
61. Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Gunther, G. et al., BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 2001. 194: 1823-1834.
62. Hutchinson, J. A., Brem-Exner, B. G., Riquelme, P., Roelen, D., Schulze, M., Ivens, K., Grabensee, B. et al., A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl. Int. 2008. 21: 742-754.
63. Hutchinson, J. A., Riquelme, P., Brem-Exner, B. G., Schulze, M., Matthai, M., Renders, L., Kunzendorf, U. et al., Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation. Transpl. Int. 2008. 21: 728-741.
64. Moroso, V., Metselaar, H. J., Mancham, S., Tilanus, H. W., Eissens, D., van der Meer, A., van der Laan, L. J. et al., Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation. Liver Transpl. 2010. 16: 895-908.